HIV/AIDS Clinical Care: Archives

SUMMARY AND COMMENT

Antiretroviral PrEP for Injection-Drug Users?

• June 17, 2013
• Carlos del Rio, MD

In a randomized, controlled trial involving injection-drug users in Thailand, tenofovir reduced the risk for HIV infection.

• Reviewing:
• Choopanya K et al., Lancet 2013 Jun 13; 381:2083

SUMMARY AND COMMENT

CMV Viremia in HIV-Infected Patients in Thailand

• June 17, 2013
• Keith Henry, MD

In a retrospective study of patients starting ART at CD4 counts <200 cells/mm³, cytomegalovirus viremia was independently associated with increased 2-year mortality.

• Reviewing:
• Durier N et al., Clin Infect Dis 2013 Jul 1; 57:147

SUMMARY AND COMMENT

ART Is Associated with Regression of HPV-Related Cervical Dysplasia in HIV-Coinfected Women

• June 17, 2013
• Sonia Nagy Chimienti, MD

Antiretroviral therapy increased the likelihood of human papillomavirus clearance.

• Reviewing:
• Blitz S et al., J Infect Dis 2013 May 24

SUMMARY AND COMMENT

Apparent Lack of Occult HIV infection Among Cancer Patients in the U.S.

• June 17, 2013
• Carlos del Rio, MD

Testing of patients at three academic cancer centers in the U.S. did not yield a single case of undiagnosed HIV infection.

• Reviewing:
• Shrestha S et al., AIDS Res Hum Retroviruses 2013 Jun; 29:887

FEATURE

PrEP Works in Injection-Drug Users — CDC Offers "Guidance"Free

• June 17, 2013

New CDC guidance on PrEP for injection-drug users is a welcome addition to the HIV prevention effort, says Dr. Paul Sax in his HIV and ID Observations blog.

SUMMARY AND COMMENT

Syphilis Responds to a Single Dose of Benzathine Penicillin

• June 10, 2013
• Abigail Zuger, MD

Data from two large cohorts in Africa suggest that extra injections are unnecessary for HIV-coinfected patients.

• Reviewing:
• Dionne-Odom J et al., Clin Infect Dis 2013 Jun 15; 56:1829

SUMMARY AND COMMENT

Resisting Drug Resistance in Resource-Constrained SettingsFree

• June 10, 2013
• Charles B. Hicks, MD

Improving access to virologic monitoring in such settings is essential to maximizing HIV treatment outcomes.

• Reviewing:
• Hosseinipour MC et al., J Infect Dis 2013 Jun 15; 207:S49

FEATURE

ID Learning Unit — AminoglycosidesFree

• June 10, 2013

Aminoglycoside prescribing has rapidly and progressively declined, says Dr. Paul Sax in his blog HIV and ID Observations, but these antibiotics still have their place.

SUMMARY AND COMMENT

B-Cell Lymphomas in HIV/HCV-Coinfected Patients

• June 10, 2013
• Rajesh T. Gandhi, MD

The histology of lymphomas in this population differs from that seen in HIV-monoinfected patients, suggesting a novel mechanism of lymphomagenesis.

• Reviewing:
• Terrier B et al., J Acquir Immune Defic Syndr 2013 Jun 1; 63:249

SUMMARY AND COMMENT

HIV/Syphilis Among MSM in China

• June 3, 2013
• Joseph D. Tucker, MD, MA

A cross-sectional analysis involving 47,231 men who have sex with men in China demonstrated a high burden of both syphilis and HIV infection.

• Reviewing:
• Wu Z et al., Clin Infect Dis 2013 May 10 Muessig KE and Cohen MS., Clin Infect Dis 2013 May 10